Biotechnology Stocks I: Returns for BeiGene, Ltd. (BGNE)
BGNE has no dividends.
Table and Chart of BGNE Performance
See what a $1,000 investment in BGNE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| BGNE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $20,209,121,000 |
| Beta | 0.630 | Price to Sales | 0.86 |
| Earnings per Share | $-8.1900 |
| PE Ratio | None |
| PE to Growth Ratio | 0 |
| Price to Book | 5.73 |
| PRICE DATA | |
| 52 Week High | $248.16 |
| 52 Week Low | $126.97 |
| Analyst Target Price | $280.92 |
| 50-Day Moving Average | $190.05 |
| 200-Day Moving Average | $180.22 |
| FINANCIAL DATA | |
| Revenue per Share | $225.24 |
| Revenue | $23,507,726,000 |
| Profit Margin | -25.5% |
| Return on Equity | -23.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
BGNE Compare Returns with S&P 500
BGNE Trendline Chart
BGNE Moving Average Chart
BGNE Stock Return Map - See Patterns of Gains and Losses
BGNE Stock Returns/Purchase Dates